I doubt it matters much in terms of getting a grant. If NIH preclinicals are positive that will be mostly what matters. Another key component was they were looking for “purse strings” to open to support this program. If I was funding a potentially billion dollar drug program I would get it off the OTC. If anything we all clearly see how ridiculous the OTC can be. I would want this drug program in a seperate entity where institutions will support thru phase 1, 2 , 3 amidst increasing valuation. Similar to what they did with OSA program In Australia.
I am long and excited for coming months. Phase 2 SCI upcoming and hopefully some news related to NIH success and grants coming as well.
This is more of a long term stock trade. I'm betting the farm on by late this fall, I will be very happy with my investment with RSPI. With everything they have in their pipeline that is coming out, I would very happy just seeing a $1 LOL. Other stocks ran to a dollar on air before. This company has treatment for CANCER for God's sakes.. This will be multiple dollars next year is my opinion.
News 
Market Data 
Discover 
